CIK 0001863127 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831476348
- Phone
- (619) 728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- 4 Open-market sale Director sold 138,711 shares at an average $16.46 ($2,282,656)
- 4 Open-market buy Chief Financial Officer bought 9,500 shares at $16.00 ($151,954)
- 4 Returned to the company See remarks returned 2,000,000 shares (to the company)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President and CEO sold 62,720 shares at an average $27.28 ($1,711,247)
- 4 Other disposition Director disposed of 1,000,000 shares (other)
- 4 Planned sale President and CEO sold 58,726 shares at an average $25.77 ($1,513,271)
- 4 Planned sale President and CEO sold 500 shares at $24.00 ($12,000)
- 4 Planned sale President and CEO sold 11,747 shares at an average $24.11 ($283,223)
- 4 Planned sale President and CEO sold 16,307 shares at an average $24.19 ($394,441)
- 4 Grant or award President and CEO acquired 1,350 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 954 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 61,392 shares (option exercise)
- 4 Planned sale Chief Operating Officer sold 3,702 shares at an average $20.00 ($74,045)
- 4 Derivatives Options or other derivatives
Page 4 of 11 · 203 filings